
10x Genomics (NASDAQ:TXG) brought in sales totaling $114.50 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 129.89%, resulting in a loss of $42.41 million. 10x Genomics collected $143.53 million in revenue during Q4, but reported earnings showed a $18.45 million loss.